Perception of screening and risk reduction surgeries in patients tested for aBRCAdeleterious mutation-Reference-Cited by-同舟云学术

Perception of screening and risk reduction surgeries in patients tested for aBRCAdeleterious mutation

Published:2009-04-15 Issue:8 Volume:115 Page:1598-1604
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Litton Jennifer K.,Westin Shannon N.,Ready Kaylene,Sun Charlotte C.,Peterson Susan K.,Meric-Bernstam Funda,Gonzalez-Angulo Ana M.,Bodurka Diane C.,Lu Karen H.,Hortobagyi Gabriel N.,Arun Banu K.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24199/fullpdf

Reference29 articles.

1. Linkage of early-onset familial breast cancer to chromosome 17q21;Hall;Science.,1990

2. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium;Easton;Am J Hum Genet.,1993

3. Localization of a breast cancer susceptibility gene, BRCA2, to 13q12-13;Wooster;Science.,1994

4. Genetics and the young woman with breast cancer;Evans;Breast Dis.,2005

5. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families;Newman;Proc Natl Acad Sci U S A.,1988

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylactic Risk‐Reducing Mastectomy (PRRM): A Set Practice or Catch‐22 Situation in LMIC. A Single‐Centre Prospective Cohort Study;World Journal of Surgery;2023-05-05

2. Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes;Cancer;2022-08-23

3. Helping Patients Understand and Cope with BRCA Mutations;Current Oncology Reports;2022-03-18

4. Influential Factors on Risk-reduction Mastectomy in a High-risk Breast Cancer Population With Genetic Predispositions;Clinical Breast Cancer;2021-08

5. Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test;Public Health Genomics;2020